GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TuHURA Biosciences Inc (NAS:HURA) » Definitions » Inventories, Other

TuHURA Biosciences (TuHURA Biosciences) Inventories, Other : $0.00 Mil (As of Dec. 2022)


View and export this data going back to 2050. Start your Free Trial

What is TuHURA Biosciences Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. TuHURA Biosciences's other inventories for the quarter that ended in Dec. 2022 was $0.00 Mil.

TuHURA Biosciences Inventories, Other Historical Data

The historical data trend for TuHURA Biosciences's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TuHURA Biosciences Inventories, Other Chart

TuHURA Biosciences Annual Data
Trend Dec21 Dec22
Inventories, Other
- -

TuHURA Biosciences Semi-Annual Data
Dec21 Dec22
Inventories, Other - -

TuHURA Biosciences Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

TuHURA Biosciences (TuHURA Biosciences) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TuHURA Biosciences Inc (NAS:HURA) » Definitions » Inventories, Other
Comparable Companies
Traded in Other Exchanges
N/A
Address
10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
Website
TuHURA Biosciences Inc is a clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment modulators to overcome resistance to current immunotherapies. The company's lead personalized cancer vaccine candidate, IFx-Hu2.0, is designed to prime the activation of the immune system to target and attack tumor cells by making them look like bacteria. Through an intratumoral injection of a gene coding for emm55, an immunogenic bacterial protein that is then expressed on the surface of tumor cells, the immune system is activated, providing a potent, multivalent systemic response against all neoantigens in a patient's tumor.

TuHURA Biosciences (TuHURA Biosciences) Headlines

No Headlines